AMRI-59 functions as a radiosensitizer via peroxiredoxin I-targeted ROS accumulation and apoptotic cell death induction
Open Access
- 9 December 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (69) , 114050-114064
Abstract
AMRI-59 functions as a radiosensitizer via peroxiredoxin I-targeted ROS accumulation and apoptotic cell death induction AMRI-59 functions as a radiosensitizer via peroxiredoxin I-targeted ROS accumulation and apoptotic cell death inductionKeywords
This publication has 41 references indexed in Scilit:
- Surgery for NSCLC in the era of personalized medicineNature Reviews Clinical Oncology, 2013
- Ionizing radiation-induced metabolic oxidative stress and prolonged cell injuryCancer Letters, 2012
- Expression of Peroxiredoxin 1, 2, 3, and 6 Genes in Cancer Cells during Drug Resistance FormationBulletin of Experimental Biology and Medicine, 2012
- Role of oxidative stress and DNA damage in human carcinogenesisMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2011
- Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinomaJournal of Experimental & Clinical Cancer Research, 2009
- Radiation-induced bystander signalling in cancer therapyNature Reviews Cancer, 2009
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- Augmented Expression of Peroxiredoxin I in Lung CancerBiochemical and Biophysical Research Communications, 2001
- Transcriptional regulation by the phosphorylation-dependent factor CREBNature Reviews Molecular Cell Biology, 2001